Back to Search
EDWARD MICHELSON, MD
MD
Emergency Medicine Physician
NPI: 1225058985IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
35-081159(OH)R2172(TX)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1982
Research & Publications (20)
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure.
PMID 19001475·Eur Heart J·2009
4-observational
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
PMID 19168515·Eur J Heart Fail·2009
8-other
Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology.
PMID 19166680·Am J Cardiol·2009
8-other
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
PMID 19196892·Diabetes Care·2009
8-other
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme.
PMID 18987098·Eur Heart J·2008
2-rct
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
PMID 19055992·J Am Coll Cardiol·2008
8-other
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
PMID 18819960·Eur Heart J·2008
4-observational
Categorization framework to aid exposure assessment of nanomaterials in consumer products.
PMID 18454314·Ecotoxicology·2008
8-other
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY).
PMID 18550933·J Clin Hypertens (Greenwich)·2008
4-observational
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
PMID 18413309·Eur Heart J·2008
2-rct
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
PMID 18695086·Arch Intern Med·2008
2-rct
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
PMID 18242128·Eur J Heart Fail·2008
2-rct
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
PMID 17638930·Circulation·2007
4-observational
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
PMID 17724259·Circulation·2007
8-other
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.
PMID 16952975·Heart·2007
4-observational
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
PMID 17188020·Eur J Heart Fail·2007
4-observational
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
PMID 17317308·Eur J Heart Fail·2007
8-other
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
PMID 17562950·Circulation·2007
4-observational
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
PMID 17601544·J Am Coll Cardiol·2007
8-other
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
PMID 17996561·J Am Coll Cardiol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4815 ALAMEDA AVE
EL PASO, TX 79905 - Phone
- (915) 215-4600
Quick Facts
- NPI
- 1225058985
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile